BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9760598)

  • 1. Ceramides and ceramide metabolites in cell regulation: evidence for dietary sphingolipids as inhibitors of colon carcinogenesis.
    Schmelz EM; Merrill AH
    Nutrition; 1998 Sep; 14(9):717-9. PubMed ID: 9760598
    [No Abstract]   [Full Text] [Related]  

  • 2. Ceramide-beta-D-glucuronide: synthesis, digestion, and suppression of early markers of colon carcinogenesis.
    Schmelz EM; Bushnev AS; Dillehay DL; Sullards MC; Liotta DC; Merrill AH
    Cancer Res; 1999 Nov; 59(22):5768-72. PubMed ID: 10582697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of sphingolipids and inhibitors of sphingolipid metabolism as components of animal diets.
    Merrill AH; Schmelz EM; Wang E; Dillehay DL; Rice LG; Meredith F; Riley RT
    J Nutr; 1997 May; 127(5 Suppl):830S-833S. PubMed ID: 9164247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingolipids in food and the emerging importance of sphingolipids to nutrition.
    Vesper H; Schmelz EM; Nikolova-Karakashian MN; Dillehay DL; Lynch DV; Merrill AH
    J Nutr; 1999 Jul; 129(7):1239-50. PubMed ID: 10395583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingolipids in the chemoprevention of colon cancer.
    Schmelz EM
    Front Biosci; 2004 Sep; 9():2632-9. PubMed ID: 15358586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of intracellular beta-catenin localization and intestinal tumorigenesis in vivo and in vitro by sphingolipids.
    Schmelz EM; Roberts PC; Kustin EM; Lemonnier LA; Sullards MC; Dillehay DL; Merrill AH
    Cancer Res; 2001 Sep; 61(18):6723-9. PubMed ID: 11559543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer and sphingolipid storage disease therapy using novel synthetic analogs of sphingolipids.
    Gatt S; Dagan A
    Chem Phys Lipids; 2012 May; 165(4):462-74. PubMed ID: 22387097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer compounds and sphingolipid metabolism in the colon.
    Duan RD
    In Vivo; 2005; 19(1):293-300. PubMed ID: 15796189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Click reactions with functional sphingolipids.
    Fink J; Seibel J
    Biol Chem; 2018 Sep; 399(10):1157-1168. PubMed ID: 29908120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Farber bodies found in murine phagocytes after injection of ceramides and related sphingolipids.
    Koga M; Ishihara T; Uchino F
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1992; 62(5):297-302. PubMed ID: 1279890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of breast xenograft growth and progression in nude mice: implications for the use of orally administered sphingolipids as chemopreventive agents against breast cancer.
    Simon KW; Tait L; Miller F; Cao C; Davy KP; LeRoith T; Schmelz EM
    Food Funct; 2010 Oct; 1(1):90-8. PubMed ID: 21776459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary sphingolipids in colorectal cancer prevention.
    Berra B; Colombo I; Sottocornola E; Giacosa A
    Eur J Cancer Prev; 2002 Apr; 11(2):193-7. PubMed ID: 11984139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingoid bases and ceramide induce apoptosis in HT-29 and HCT-116 human colon cancer cells.
    Ahn EH; Schroeder JJ
    Exp Biol Med (Maywood); 2002 May; 227(5):345-53. PubMed ID: 11976405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoprevention of colon carcinogenesis by phenylethyl-3-methylcaffeate.
    Rao CV; Desai D; Rivenson A; Simi B; Amin S; Reddy BS
    Cancer Res; 1995 Jun; 55(11):2310-5. PubMed ID: 7757981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingolipids in apoptosis.
    Tirodkar TS; Voelkel-Johnson C
    Exp Oncol; 2012 Oct; 34(3):231-42. PubMed ID: 23070008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingosine Kinase 2 and Ceramide Transport as Key Targets of the Natural Flavonoid Luteolin to Induce Apoptosis in Colon Cancer Cells.
    Abdel Hadi L; Di Vito C; Marfia G; Ferraretto A; Tringali C; Viani P; Riboni L
    PLoS One; 2015; 10(11):e0143384. PubMed ID: 26580959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingomyelin consumption suppresses aberrant colonic crypt foci and increases the proportion of adenomas versus adenocarcinomas in CF1 mice treated with 1,2-dimethylhydrazine: implications for dietary sphingolipids and colon carcinogenesis.
    Schmelz EM; Dillehay DL; Webb SK; Reiter A; Adams J; Merrill AH
    Cancer Res; 1996 Nov; 56(21):4936-41. PubMed ID: 8895747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nobiletin and its colonic metabolites suppress colitis-associated colon carcinogenesis by down-regulating iNOS, inducing antioxidative enzymes and arresting cell cycle progression.
    Wu X; Song M; Gao Z; Sun Y; Wang M; Li F; Zheng J; Xiao H
    J Nutr Biochem; 2017 Apr; 42():17-25. PubMed ID: 28107678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smart drugs for smarter stem cells: making SENSe (sphingolipid-enhanced neural stem cells) of ceramide.
    Bieberich E
    Neurosignals; 2008; 16(2-3):124-39. PubMed ID: 18253053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceramide Metabolism Balance, a Multifaceted Factor in Critical Steps of Breast Cancer Development.
    García-González V; Díaz-Villanueva JF; Galindo-Hernández O; Martínez-Navarro I; Hurtado-Ureta G; Pérez-Arias AA
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.